Renaissance Technologies - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 49 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$358
-62.9%
48,302
-52.7%
0.00%0.0%
Q1 2023$966
-43.2%
102,200
-36.0%
0.00%
-50.0%
Q4 2022$1,700
-99.7%
159,600
+103.8%
0.00%
+100.0%
Q3 2022$578,000
+107.9%
78,300
+35.7%
0.00%
Q2 2022$278,00057,7000.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sentinus, LLC 149,050$1,408,5230.47%
Intrepid Financial Planning Group LLC 19,000$179,5500.09%
PERRITT CAPITAL MANAGEMENT INC 12,000$113,4000.06%
Interchange Capital Partners, LLC 11,413$107,8530.06%
Virtu Financial LLC 21,650$2050.02%
CREATIVE FINANCIAL DESIGNS INC /ADV 15,000$141,7500.02%
J. Goldman & Co LP 42,228$399,0550.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 63,966$604,4790.02%
KENNEDY CAPITAL MANAGEMENT LLC 46,311$437,6390.01%
683 Capital Management, LLC 16,000$151,2000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders